Conrad Crisafulli
Corporate Advisor

Conrad has extensive experience in all aspects of technology commercialisation.

He recently stepped down from the role of Director for IP Commercialisation at Curtin University of Technology where, over five years, he established an immensely successful technology commercialization business. Prior to that he was the managing director of TechStart Australia Pty Ltd (a boutique venture capital firm) and was involved in various investee companies.

Conrad has also had many years of experience in senior management roles in the energy and telecommunications industries. He was previously Commercial Manager at QPSX Communications Pty Ltd from 1990 to 1998 and was responsible for the commercialisation of the patent portfolio. This included the negotiation and management of licence agreements, joint development and worldwide marketing arrangements and ongoing liaison with telecommunication equipment vendors such as Siemens and Alcatel. Subsequent to this, Conrad has been a non-executive director of ipernica Ltd (formerly QPSX Ltd), an intellectual property commercialisation company listed on the Australian stock exchange, since October 2000.

He has had an involvement in bringing a number of animal and human health technologies to market, including VectoGen Ltd (of which he was also a director up to the date of its trade sale to the ASX-listed Imugene Ltd). Conrad is a past chairman and a current non-executive director of the Sydney University biotechnology start-up ZingoTX Pty Ltd.

Conrad is a director of several start-up technology ventures including Virtual Observer Pty Ltd, Medevco Pty Ltd (chair) and Sea Gyro Pty Ltd. He recently joined the board of Entellect Solutions Ltd (ASX:ENS).